State of the Society from Flora Peyvandi

ISTH President Flora Peyvandi, M.D., Ph.D., gives an update on the state of the ISTH and the strategic plans for growth.

Previous Article Andexanet alfa is associated with lower in-hospital mortality compared to 4-factor prothrombin complex concentrate in patients with factor Xa inhibitor-related major bleeding
Next Article Living with hemophilia: How the Canadian Hemophilia Society advocates for a better future